Deng G, Muqadas M, Adlat S, Zheng H, Li G, Zhu P
Cell Mol Neurobiol. 2022; 43(1):15-25.
PMID: 35066714
PMC: 11415178.
DOI: 10.1007/s10571-021-01166-4.
Ong C, Patchett A, Darby J, Chen J, Liu G, Lyons A
J Cancer Res Clin Oncol. 2021; 147(7):1973-1991.
PMID: 33797607
PMC: 8017436.
DOI: 10.1007/s00432-021-03601-x.
Sullivan K, Evans D, Pandey A, Hraha T, Smith K, Markham N
Sci Rep. 2017; 7(1):14818.
PMID: 29093484
PMC: 5665944.
DOI: 10.1038/s41598-017-13858-3.
Jiang J, Natarajan K, Boyd L, Morozov G, Mage M, Margulies D
Science. 2017; 358(6366):1064-1068.
PMID: 29025991
PMC: 6320693.
DOI: 10.1126/science.aao5154.
Natarajan K, McShan A, Jiang J, Kumirov V, Wang R, Zhao H
Nat Commun. 2017; 8:15260.
PMID: 28508865
PMC: 5440810.
DOI: 10.1038/ncomms15260.
Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing.
Morozov G, Zhao H, Mage M, Boyd L, Jiang J, Dolan M
Proc Natl Acad Sci U S A. 2016; 113(8):E1006-15.
PMID: 26869717
PMC: 4776512.
DOI: 10.1073/pnas.1519894113.
Reduced expression of members of the mhc-i antigen processing machinery in ethnic Uighur women with cervical cancer in the Xinjiang region of China.
Haimiti A, Hailiman Y, Gulina A, Du J, Hao Z, Rong X
Curr Oncol. 2014; 21(1):e67-74.
PMID: 24523623
PMC: 3921050.
DOI: 10.3747/co.21.1595.
Structure of an early native-like intermediate of β2-microglobulin amyloidogenesis.
Vanderhaegen S, Fislage M, Domanska K, Versees W, Pardon E, Bellotti V
Protein Sci. 2013; 22(10):1349-57.
PMID: 23904325
PMC: 3795493.
DOI: 10.1002/pro.2321.
Different vaccine vectors delivering the same antigen elicit CD8+ T cell responses with distinct clonotype and epitope specificity.
Honda M, Wang R, Kong W, Kanekiyo M, Akahata W, Xu L
J Immunol. 2009; 183(4):2425-34.
PMID: 19620307
PMC: 2858449.
DOI: 10.4049/jimmunol.0900581.
Using a baculovirus display library to identify MHC class I mimotopes.
Wang Y, Rubtsov A, Heiser R, White J, Crawford F, Marrack P
Proc Natl Acad Sci U S A. 2005; 102(7):2476-81.
PMID: 15699351
PMC: 548325.
DOI: 10.1073/pnas.0409798102.
Supraoptimal peptide-major histocompatibility complex causes a decrease in bc1-2 levels and allows tumor necrosis factor alpha receptor II-mediated apoptosis of cytotoxic T lymphocytes.
Derby M, Sarin A, Henkart P, Berzofsky J
J Exp Med. 1998; 188(8):1391-9.
PMID: 9782116
PMC: 2213409.
DOI: 10.1084/jem.188.8.1391.
An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule.
Horig H, Papadopoulos N, Vegh Z, Palmieri E, Angeletti R, Nathenson S
Proc Natl Acad Sci U S A. 1998; 94(25):13826-31.
PMID: 9391112
PMC: 28392.
DOI: 10.1073/pnas.94.25.13826.
A T cell receptor V alpha domain expressed in bacteria: does it dimerize in solution?.
Plaksin D, Chacko S, McPhie P, Bax A, Padlan E, Margulies D
J Exp Med. 1996; 184(4):1251-8.
PMID: 8879196
PMC: 2192823.
DOI: 10.1084/jem.184.4.1251.
Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.
Tsai S, Chen M, Yeh C, Chu C, Lin A, Chiou F
J Clin Invest. 1996; 97(2):577-84.
PMID: 8567982
PMC: 507052.
DOI: 10.1172/JCI118450.
Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced.
Boniface J, Lyons D, Wettstein D, Allbritton N, Davis M
J Exp Med. 1996; 183(1):119-26.
PMID: 8551214
PMC: 2192414.
DOI: 10.1084/jem.183.1.119.
Murine cytomegalovirus interacts with major histocompatibility complex class I molecules to establish cellular infection.
Wykes M, Shellam G, McCluskey J, Kast W, Dallas P, Price P
J Virol. 1993; 67(7):4182-9.
PMID: 8389923
PMC: 237787.
DOI: 10.1128/JVI.67.7.4182-4189.1993.
Characterization of an incompletely assembled major histocompatibility class I molecule (H-2Kb) associated with unusually long peptides: implications for antigen processing and presentation.
Joyce S, Kuzushima K, Kepecs G, Angeletti R, Nathenson S
Proc Natl Acad Sci U S A. 1994; 91(10):4145-9.
PMID: 8183884
PMC: 43741.
DOI: 10.1073/pnas.91.10.4145.
Intracellular transport of class I HLA molecules is affected by polymorphic residues in the binding groove.
Salter R
Immunogenetics. 1994; 39(4):266-71.
PMID: 8119733
DOI: 10.1007/BF00188789.
Monte Carlo study of the effect of beta 2-microglobulin on the binding cleft of the HLA-A2 complex.
Bouzida D, Garnier J, Brower R, Cornette J, Delisi C
Protein Sci. 1994; 3(6):911-9.
PMID: 8069222
PMC: 2142884.
DOI: 10.1002/pro.5560030606.
The class I-b molecule Qa-1 forms heterodimers with H-2Ld and a novel 50-kD glycoprotein encoded centromeric to I-E beta.
Wolf P, Cook R
J Exp Med. 1995; 181(2):657-68.
PMID: 7836920
PMC: 2191872.
DOI: 10.1084/jem.181.2.657.